Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07217626Phase 4Recruiting
A Phase 4 trial of ropivacaine in lower extremity fracture, sponsored by University of Maryland, Baltimore. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07217626.